Skip to main content
. 2019 Dec 26;35(2):383–391. doi: 10.3904/kjim.2019.002

Table 5.

Difference in IFN-γ level between TB2 and TB1 ([TB2-TB1] > 0.6 IU/mL) based on TB infection risk in subjects with QFT-PLUS–positive results (n = 44)

TB2-TB1, IU/mL Active TB/TB contact Biologic therapy/other diseases Total
> 0.6 5 4 9
≤ 0.6 14 21 35
Total 19 25 44

IFN-γ, interferon-γ; TB, tuberculosis; QFT-PLUS, QuantiFERON-TB Gold Plus.